ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

December 5, 2014

NCCS Networker Volume 8 Issue 3, Fall 1994

September 12, 1994

NCI advisors approve $50 million pilot for Human Cancer Genome Project; NHLBI Director Collins calls it a “unique, historic opportunity.”

November 18, 2005

NCI names Porter Novelli executive as director for strategic dissemination.

August 1, 2003

Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate.

October 10, 2008